& Cozzolino, M
Proper sterile injection technique and handling are essential to ensure safety and efficacy
GLP-1 Receptor Agonists More and more clinicians are using GLP-1s off-label in people with type 1 diabetes, particularly in those who also have obesity or high insulin requirements, says Mihail Zilbermint, MD, an associate professor of medicine at Johns Hopkins University School of Medicine and the chief of the division of endocrinology, diabetes, and metabolism at Suburban Hospital in Maryland
Early Parkinsons trials have shown mixed results, and Alzheimers trials are In the intestine and joints, GLP-1 agonists reduce intestinal inflammation in colitis models and may benefit osteoarthritis by reducing synovitis and chondrocyte inflammation
Those with diabetic retinopathy, glaucoma, macular degeneration, or other chronic eye diseases should inform their healthcare provider before starting Zepbound